ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation

References

• Ehrlich M. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin Immunol 2003; 109: 17–28
   PubMed Web of Science ®Google Scholar
• Hansen RS, Wijmenga C, Luo P, Stanek AM, Canfield TK, Weemaes CM, Gartler SM. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci USA 1999; 96: 14412–14417
   PubMed Web of Science ®Google Scholar
• Okano M, Takebayashi S, Okumura K, Li E. Assignment of cytosine-5 DNA methyltransferases Dnmt3a and Dnmt3b to mouse chromosome bands 12A2-A3 and 2H1 by in situ hybridization. Cytogenet Cell Genet 1999; 86: 333–334
   Google Scholar
• Xu G, Bestor TH, Bourc'his D, Hsieh C, Tommerup N, Hulten M, Qu S, Russo JJ, Viegas-Péquignot E. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999; 402: 187–191
   PubMed Web of Science ®Google Scholar
• Ehrlich M, Buchanan K, Tsien F, Jiang G, Sun B, Uicker W, Weemaes C, Smeets D, Sperling K, Belohradsky B, et al. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum Mol Gen 2001; 10: 2917–2931
   PubMed Web of Science ®Google Scholar
• Wijmenga C, Hansen RS, Gimelli G, Bjorck EJ, Davies EG, Valentine D, Belohradsky BH, van Dongen JJ, Smeets DF, van den Heuvel LP, et al. Genetic variation in ICF syndrome: Evidence for genetic heterogeneity. Hum Mutat 2000; 16: 509–517
   PubMed Web of Science ®Google Scholar
• Jiang YL, Rigolet M, Bourc'his D, Nigon F, Bokesoy I, Fryns JP, Hulten M, Jonveaux P, Maraschio P, Megarbane A, et al. DNMT3B mutations and DNA methylation defect define two types of ICF syndrome. Hum Mutat 2005; 25: 56–63
   Google Scholar
• Kubota T, Furuumi H, Kamoda T, Iwasaki N, Tobita N, Fujiwara N, Goto Y, Matsui A, Sasaki H, Kajii T. ICF syndrome in a girl with DNA hypomethylation but without detectable DNMT3B mutation. Am J Med Genet 2004; 129A: 290–293
   Google Scholar
• Ehrlich M, Jackson K, Weemaes C. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis 2006; 1: 2
   PubMed Web of Science ®Google Scholar
• Hagleitner M, Lankester A, Maraschio P, Hulten M, Fryns J, Schuetz C, Gimelli G, Davies E, Gennery A, Belohradsky B, et al. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF-syndrome). J Med Genet 2007
   Google Scholar
• Hulten M. Selective somatic pairing and fragility at 1q12 in a boy with common variable immunodeficiency. Clin Genet 1978; 14: 294
   Google Scholar
• Tiepolo L, Maraschio P, Gimelli G, Cuoco C, Gargani GF, Romano C. Multibranched chromosomes 1, 9, and 16 in a patient with combined IgA and IgE deficiency. Hum Genet 1979; 51: 127–137
   PubMed Web of Science ®Google Scholar
• Jeanpierre M, Turleau C, Aurias A, Prieur M, Ledeist F, Fischer A, Viegas-Pequignot E. An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum Mol Genet 1993; 2: 731–735
   PubMedGoogle Scholar
• Tuck-Muller CM, Narayan A, Tsien F, Smeets D, Sawyer J, Fiala ES, Sohn O, Ehrlich M. DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogen Cell Genet 2000; 89: 121–128
   PubMedGoogle Scholar
• Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 98: 247–257
   Google Scholar
• Gowher H, Jeltsch A. Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases. J Biol Chem 2002; 277: 20409–20414
   PubMed Web of Science ®Google Scholar
• Ueda Y, Okano M, Williams C, Chen T, Georgopoulos K, Li E. Roles for Dnmt3b in mammalian development: A mouse model for the ICF syndrome. Development 2006; 133: 1183–1192
   PubMedGoogle Scholar
• Xie S, Wang Z, Okano M, Nogami M, Li Y, He WW, Okumura K, Li E. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene 1999; 236: 87–95
   PubMed Web of Science ®Google Scholar
• Jeltsch A. Molecular enzymology of mammalian DNA methyltransferases. Curr Top Microbiol Immunol 2006; 301: 203–225
   PubMed Web of Science ®Google Scholar
• Kato Y, Kaneda M, Hata K, Kumaki K, Hisano M, Kohara Y, Okano M, Li E, Nozaki M, Sasaki H. Role of the Dnmt3 family in de novo methylation of imprinted and repetitive sequences during male germ cell development in the mouse. Hum Mol Genet 2007; 16: 2272–2280
   PubMed Web of Science ®Google Scholar
• Lucifero D, La Salle S, Bourc'his D, Martel J, Bestor TH, Trasler JM. Coordinate regulation of DNA methyltransferase expression during oogenesis. BMC Dev Biol 2007; 7: 36
   PubMed Web of Science ®Google Scholar
• Turek-Plewa J, Jagodzinski PP. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 2005; 10: 631–647
   PubMed Web of Science ®Google Scholar
• Feng J, Chang H, Li E, Fan G. Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system. J Neurosci Res 2005; 79: 734–746
   PubMed Web of Science ®Google Scholar
• Li JY, Pu MT, Hirasawa R, Li BZ, Huang YN, Zeng R, Jing NH, Chen T, Li E, Sasaki H, et al. Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. Mol Cell Biol 2007
   Google Scholar
• Suetake I, Miyazaki J, Murakami C, Takeshima H, Tajima S. Distinct enzymatic properties of recombinant mouse DNA methyltransferases Dnmt3a and Dnmt3b. J Biochem (Tokyo) 2003; 133: 737–744
   PubMedGoogle Scholar
• Takeshima H, Suetake I, Shimahara H, Ura K, Tate S, Tajima S. Distinct DNA methylation activity of Dnmt3a and Dnmt3b towards naked and nucleosomal DNA. J Biochem (Tokyo) 2006; 139: 503–515
   PubMedGoogle Scholar
• Weisenberger DJ, Velicescu M, Cheng JC, Gonzales FA, Liang G, Jones PA. Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. Mol Cancer Res 2004; 2: 62–72
   PubMed Web of Science ®Google Scholar
• Shirohzu H, Kubota T, Kumazawa A, Sado T, Chijiwa T, Inagaki K, Suetake I, Tajima S, Wakui K, Miki Y, et al. Three novel DNMT3B mutations in Japanese patients with ICF syndrome. Am J Med Genet 2002; 112: 31–37
   PubMed Web of Science ®Google Scholar
• Hernandez R, Frady A, Zhang X-Y, Varela M, Ehrlich M. Preferential induction of chromosome 1 multibranched figures and whole-arm deletions in a human pro-B cell line treated with 5-azacytidine or 5-azadeoxycytidine. Cytogenet Cell Genet 1997; 76: 196–201
   Google Scholar
• Ji W, Hernandez R, Zhang X-Y, Qu G, Frady A, Varela M, Ehrlich M. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutation Res 1997; 379: 33–41
   PubMed Web of Science ®Google Scholar
• Bachman KE, Rountree MR, Baylin SB. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem 2001; 276: 32282–32287
   PubMed Web of Science ®Google Scholar
• Kang ES, Park CW, Chung JH. Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1. Biochem Biophys Res Commun 2001; 289: 862–868
   Google Scholar
• Kim GD, Ni J, Kelesoglu N, Roberts RJ, Pradhan S. Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J 2002; 21: 4183–4195
   PubMed Web of Science ®Google Scholar
• Geiman TM, Sankpal UT, Robertson AK, Zhao Y, Zhao Y, Robertson KD. DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system. Biochem Biophys Res Commun 2004; 318: 544–555
   PubMed Web of Science ®Google Scholar
• Geiman TM, Sankpal UT, Robertson AK, Chen Y, Mazumdar M, Heale JT, Schmiesing JA, Kim W, Yokomori K, Zhao Y, et al. Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. Nucleic Acids Res 2004; 32: 2716–2729
   PubMedGoogle Scholar
• Gill G. SUMO and ubiquitin in the nucleus: Different functions, similar mechanisms?. Genes Dev 2004; 18: 2046–2059
   PubMed Web of Science ®Google Scholar
• Heun P. SUMOrganization of the nucleus. Curr Opin Cell Biol 2007; 19: 350–355
   PubMed Web of Science ®Google Scholar
• Ge YZ, Pu MT, Gowher H, Wu HP, Ding JP, Jeltsch A, Xu GL. Chromatin targeting of de novo DNA methyltransferases by the PWWP domain. J Biol Chem 2004; 279: 25447–25454
   PubMedGoogle Scholar
• Luciani JJ, Depetris D, Usson Y, Metzler-Guillemain C, Mignon-Ravix C, Mitchell MJ, Megarbane A, Sarda P, Sirma H, Moncla A. PML nuclear bodies are highly organised DNA–protein structures with a function in heterochromatin remodelling at the G2 phase. J Cell Sci 2006; 119: 2518–2531
   PubMedGoogle Scholar
• Luciani JJ, Depetris D, Missirian C, Mignon-Ravix C, Metzler-Guillemain C, Megarbane A, Moncla A, Mattei MG. Subcellular distribution of HP1 proteins is altered in ICF syndrome. Eur J Hum Genet 2005; 13: 41–51
   Google Scholar
• Bai S, Ghoshal K, Datta J, Majumder S, Yoon SO, Jacob ST. DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2. Mol Cell Biol 2005; 25: 751–766
   PubMed Web of Science ®Google Scholar
• Bai S, Ghoshal K, Jacob ST. Identification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cells. J Biol Chem 2006; 281: 13604–13611
   Google Scholar
• Xie ZH, Huang YN, Chen ZX, Riggs AD, Ding JP, Gowher H, Jeltsch A, Sasaki H, Hata K, Xu GL. Mutations in DNA methyltransferase DNMT3B in ICF syndrome affect its regulation by DNMT3L. Hum Mol Genet 2006; 15: 1375–1385
   PubMedGoogle Scholar
• Margot JB, Ehrenhofer-Murray AE, Leonhardt H. Interactions within the mammalian DNA methyltransferase family. BMC Mol Biol 2003; 4: 7
   PubMed Web of Science ®Google Scholar
• Suetake I, Shinozaki F, Miyagawa J, Takeshima H, Tajima S. DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction. J Biol Chem 2004; 279: 27816–27823
   PubMed Web of Science ®Google Scholar
• Kareta MS, Botello ZM, Ennis JJ, Chou C, Chedin F. Reconstitution and mechanism of the stimulation of de novo methylation by human DNMT3L. J Biol Chem 2006; 281: 25893–25902
   Google Scholar
• Kloeckener-Gruissem B, Betts DR, Zankl A, Berger W, Gungor T. A new and a reclassified ICF patient without mutations in DNMT3B and its interacting proteins SUMO-1 and UBC9. Am J Med Genet A 2005; 136: 31–37
   PubMed Web of Science ®Google Scholar
• Miniou P, Jeanpierre M, Bourc'his D, Coutinho Barbosa AC, Blanquet V, Viegas-Pequignot E. Alpha-satellite DNA methylation in normal individuals and in ICF patients: Heterogeneous methylation of constitutive heterochromatin in adult and fetal tissues. Hum Genet 1997; 99: 738–745
   Google Scholar
• Howard PJ, Lewis IJ, Harris F, Walker S. Centromeric instability of chromosomes 1 and 16 with variable immune deficiency: A new syndrome. Clin Genet 1985; 27: 501–505
   Google Scholar
• Gimelli G, Varone P, Pezzolo A, Lerone M, Pistoia V. ICF syndrome with variable expression in sibs. J Med Gen 1993; 30: 429–432
   PubMed Web of Science ®Google Scholar
• Hansen RS, Stoger R, Wijmenga C, Stanek AM, Canfield TK, Luo P, Matarazzo MR, D'Esposito M, Feil R, Gimelli G, et al. Escape from gene silencing in ICF syndrome: Evidence for advanced replication time as a major determinant. Hum Mol Genet 2000; 9: 2575–2587
   PubMed Web of Science ®Google Scholar
• Schuffenhauer S, Bartsch O, Stumm M, Buchholz T, Petropoulou T, Kraft S, Belohradsky B, Meitinger T, Wegner R. DNA, FISH and complementation studies in ICF syndrome; DNA hypomethylation of repetitive and single copy loci and evidence for a trans acting factor. Hum Genet 1995; 96: 562–571
   PubMed Web of Science ®Google Scholar
• Smeets DFCM, Moog U, Weemaes CMR, Vaes-Peeters G, Merkx GFM, Niehof JP, Hamers G. ICF syndrome: A new case and review of the literature. Hum Genet 1994; 94: 240–246
   PubMed Web of Science ®Google Scholar
• Ausio J, Levin DB, De Amorim GV, Bakker S, Macleod PM. Syndromes of disordered chromatin remodeling. Clin Genet 2003; 64: 83–95
   PubMed Web of Science ®Google Scholar
• Maraschio P, Zuffardi O, Dalla Fior T, Tiepolo L. Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: The ICF syndrome. J Med Genet 1988; 25: 173–180
   PubMed Web of Science ®Google Scholar
• Turleau C, Cabanis M-O, Girault D, Ledeist F, Mettey R, Puissant H, Marguerite P, de Grouchy J. Multibranched chromosomes in the ICF syndrome: Immunodeficiency, centromeric instability, and facial anomalies. Am J Med Genet 1989; 32: 420–424
   Google Scholar
• Franceschini P, Martino S, Ciocchini M, Ciuti E, Vardeu MP, Guala A, Signorile F, Camerano P, Franceschini D, Tovo PA. Variability of clinical and immunological phenotype in immunodeficiency–centromeric instability–facial anomalies syndrome. Report of two new patients and review of the literature. Eur J Pediatr 1995; 154: 840–846
   PubMed Web of Science ®Google Scholar
• Fasth A, Forestier E, Holmberg E, Holmgren G, Nordenson I, Soderstrom T, Wahlstrom J. Fragility of the centromeric region of chromosome 1 associated with combined immunodeficiency in siblings: A recessively inherited entity?. Acta Paediatr Scand 1990; 79: 605–612
   Google Scholar
• Dodge JE, Okano M, Dick F, Tsujimoto N, Chen T, Wang S, Ueda Y, Dyson N, Li E. Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. J Biol Chem 2005; 280: 17986–17991
   PubMed Web of Science ®Google Scholar
• Miniou P, Jeanpierre M, Blanquet V, Sibella V, Bonneau D, Herbelin C, Fischer A, Niveleau A, Viegas-Pequignot ET. Abnormal methylation pattern in constitutive and facultative (X inactive chromosome) heterochromatin of ICF patients. Hum Mol Genet 1994; 3: 2093–2102
   PubMed Web of Science ®Google Scholar
• Ehrlich M. DNA methylation in cancer: Too much, but also too little. Oncogene 2002; 21: 5400–5413
   PubMed Web of Science ®Google Scholar
• Hassan KM, Norwood T, Gimelli G, Gartler SM, Hansen RS. Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication. Hum Genet 2001; 109: 452–462
   Google Scholar
• Bourc'his D, Miniou P, Jeanpierre M, Molina Gomes D, Dupont J, De Saint-Basile G, Maraschio P, Tiepolo L, Viegas-Pequignot E. Abnormal methylation does not prevent X inactivation in ICF patients. Cytogenet Cell Genet 1999; 84: 245–252
   Google Scholar
• Hansen RS. X inactivation-specific methylation of LINE-1 elements by DNMT3B: Implications for the Lyon repeat hypothesis. Hum Mol Gen 2003; 12: 2559–2567
   PubMedGoogle Scholar
• Kondo T, Comenge Y, Bobek MP, Kuick R, Lamb B, Zhu X, Narayan A, Bourc'his D, Viegas-Pequinot E, Ehrlich M, et al. Whole-genome methylation scan in ICF syndrome: Hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum Mol Gen 2000; 9: 597–604
   PubMed Web of Science ®Google Scholar
• Tsien F, Sun B, Hopkins NE, Vedanarayanan V, Figlewicz D, Winokur S, Ehrlich M. Hypermethylation of the FSHD syndrome-associated D4Z4 repeat in normal somatic tissues and FSHD lymphoblastoid cell lines but not in ICF lymphoblastoid cell lines. Mol Gen Metab 2000; 74: 322–331
   Google Scholar
• Nishiyama R, Qi L, Lacey M, Ehrlich M. Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer. Mol Cancer Res 2005; 3: 617–626
   PubMed Web of Science ®Google Scholar
• Narayan A, Ji W, Zhang X-Y, Marrogi A, Graff JR, Baylin SB, Ehrlich M. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 1998; 77: 833–838
   PubMed Web of Science ®Google Scholar
• Qu G, Dubeau L, Narayan A, Yu M, Ehrlich M. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mutat Res 1999; 423: 91–101
   PubMed Web of Science ®Google Scholar
• Sanford J, Forrester L, Chapman V, Chandley A, Hastie N. Methylation patterns of repetitive DNA sequences in germ cells of Mus musculus. Nucleic Acids Res 1984; 12: 2823–2836
   PubMedGoogle Scholar
• Sanford JP, Clark HJ, Chapman VM, Rossant J. Differences in DNA methylation during oogenesis and spermatogenesis and their persistence during early embryogenesis in the mouse. Genes Dev 1987; 1: 1039–1046
   PubMed Web of Science ®Google Scholar
• Howlett SK, Reik W. Methylation levels of maternal and paternal genomes during preimplantation development. Development 1991; 113: 119–127
   PubMedGoogle Scholar
• Govin J, Escoffier E, Rousseaux S, Kuhn L, Ferro M, Thevenon J, Catena R, Davidson I, Garin J, Khochbin S, et al. Pericentric heterochromatin reprogramming by new histone variants during mouse spermiogenesis. J Cell Biol 2007; 176: 283–294
   PubMed Web of Science ®Google Scholar
• Kress C, Thomassin H, Grange T. Active cytosine demethylation triggered by a nuclear receptor involves DNA strand breaks. Proc Natl Acad Sci USA 2006; 103: 11112–11117
   PubMedGoogle Scholar
• Yamazaki T, Yamagata K, Baba T. Time-lapse and retrospective analysis of DNA methylation in mouse preimplantation embryos by live cell imaging. Dev Biol 2007; 304: 409–419
   PubMed Web of Science ®Google Scholar
• Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 1983; 11: 6883–6894
   PubMed Web of Science ®Google Scholar
• Ehrlich M. Cancer-linked DNA hypomethylation and its relationship to hypermethylation. Curr Top Microbiol Immunol 2006; 310: 251–274
   PubMed Web of Science ®Google Scholar
• Sumner AT. Scanning electron microscopy of mammalian chromosomes from prophase to telophase. Chromosoma 1991; 100: 410–418
   PubMed Web of Science ®Google Scholar
• Maraschio P, Cortinovis M, Dainotti E, Tupler R, Tiepolo L. Interphase cytogenetics of the ICF syndrome. Ann Hum Genet 1992; 56: 273–278
   Google Scholar
• Gisselsson D, Shao C, Tuck-Muller C, Sogorovic S, Palsson E, Smeets D, Ehrlich M. Pericentromeric chromosomal abnormalities in hypomethylated sequences of ICF syndrome cells at interphase, metaphase, and anaphase. Chromosoma 2005; 114: 118–126
   Google Scholar
• Haaf T. The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: Implications for methylation-associated cellular processes. Pharmacol Ther 1995; 65: 19–46
   PubMed Web of Science ®Google Scholar
• Almeida A, Kokalj-Vokac N, Lefrancois D, Viegas-Pequignot E, Jeanpierre M, Dutrillaux B, Malfoy B. Hypomethylation of classical satellite DNA and chromosome instability in lymphoblastoid cell lines. Hum Genet 1993; 91: 538–546
   PubMed Web of Science ®Google Scholar
• Vilain A, Bernardino J, Gerbault-Seureau M, Vogt N, Niveleau A, Lefrancois D, Malfoy B, Dutrillaux B. DNA methylation and chromosome instability in lymphoblastoid cell lines. Cytogenet Cell Genet 2000; 90: 93–101
   Google Scholar
• Tsien F, Fiala ES, Youn B, Long TI, Laird PW, Weissbecker K, Ehrlich M. Prolonged culture of normal chorionic villus cells yields ICF syndrome-like chromatin decondensation and rearrangements. Cytogenet Genome Res 2002; 98: 13–21
   Google Scholar
• Brown DC, Grace E, Summer AT, Edmunds AT, Ellis PM. ICF syndrome (immunodeficiency, centromeric instability and facial anomalies): Investigation of heterochromatin abnormalities and review of clinical outcome. Hum Genet 1995; 96: 411–416
   Google Scholar
• Sawyer JR, Swanson CM, Wheeler G, Cunniff C. Chromosome instability in ICF syndrome: Formation of micronuclei from multibranched chromosome 1 demonstrated by fluorescence in situ hybridization. Am J Med Genet 1995; 56: 203–209
   Google Scholar
• Ehrlich M. DNA methylation and cancer-associated genetic instability. Genomic instability in cancer development, EA Nigg. Kluwer Academic Publishers, Amsterdam 2005; Vol. 570: 363–392, Advances in Experimental Medicine and Biology
   Google Scholar
• Sawyer J, Tricot G, Mattox S, Jagannath S, Barlogie B. Jumping translocations of chromosome 1q in multiple myeloma: Evidence for a mechanism involving decondensation of pericentromeric heterochromatin. Blood 1998; 91: 1732–1741
   PubMed Web of Science ®Google Scholar
• Wong N, Lam WC, Lai PB, Pang E, Lau WY, Johnson PJ. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am J Pathol 2001; 159: 465–471
   PubMedGoogle Scholar
• Nakagawa T, Kanai Y, Ushijima S, Kitamura T, Kakizoe T, Hirohashi S. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas. J Urol 2005; 173: 243–246
   PubMed Web of Science ®Google Scholar
• Cadieux B, Ching TT, Vandenberg SR, Costello JF. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res 2006; 66: 8469–8476
   PubMed Web of Science ®Google Scholar
• Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 1997; 15: 417–474
   PubMed Web of Science ®Google Scholar
• Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300: 455
   PubMed Web of Science ®Google Scholar
• Yamada Y, Jackson-Grusby L, Linhart H, Meissner A, Eden A, Lin H, Jaenisch R. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci USA 2005; 102: 13580–13585
   PubMed Web of Science ®Google Scholar
• Schuetz C, Barbi G, Barth TF, Hoenig M, Schulz A, Moeller P, Smeets D, de Greef JC, van der Maarel SM, Vogel W, et al. ICF syndrome: High variability of the chromosomal phenotype and association with classical Hodgkin lymphoma. Am J Med Genet A 2007; 143: 2052–2057
   Google Scholar
• Narayan A, Tuck-Muller C, Weissbecker K, Smeets D, Ehrlich M. Hypersensitivity to radiation-induced non-apoptotic and apoptotic death in cell lines from patients with the ICF chromosome instability syndrome. Mutat Res 2000; 456: 1–15
   Google Scholar
• Seidemann K, Henze G, Beck JD, Sauerbrey A, Kuhl J, Mann G, Reiter A. Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): Experience from the BFM trials. Ann Oncol 2000; 11(Suppl 1)141–145
   PubMedGoogle Scholar
• Blanco-Betancourt CE, Moncla A, Milili M, Jiang Y, Viegas-Pequignot E, Roquelaure B, Thuret I, Schiff C. Defective B-cell-negative selection and terminal differentiation in the ICF syndrome. Blood 2004; 2683–2690
   Google Scholar
• Mack KD, Von Goetz M, Lin M, Venegas M, Barnhart J, Lu Y, Lamar B, Stull R, Silvin C, Owings P, et al. Functional identification of kinases essential for T-cell activation through a genetic suppression screen. Immunol Lett 2005; 96: 129–145
   PubMed Web of Science ®Google Scholar
• Yao Z, Zhou G, Wang XS, Brown A, Diener K, Gan H, Tan TH. A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway. J Biol Chem 1999; 274: 2118–2125
   PubMed Web of Science ®Google Scholar
• Miled C, Pontoglio M, Garbay S, Yaniv M, Weitzman JB. A genomic map of p53 binding sites identifies novel p53 targets involved in an apoptotic network. Cancer Res 2005; 65: 5096–5104
   PubMed Web of Science ®Google Scholar
• Tesz GJ, Guilherme A, Guntur KV, Hubbard AC, Tang X, Chawla A, Czech MP. Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. J Biol Chem 2007; 282: 19302–19312
   Google Scholar
• Collins CS, Hong J, Sapinoso L, Zhou Y, Liu Z, Micklash K, Schultz PG, Hampton GM. A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase. Proc Natl Acad Sci USA 2006; 103: 3775–3780
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Hooker SW, Jiang H, Laurent AB, Resta R, Khare K, Coe A, Kincade PW, Thompson LF. CD73 expression and fyn-dependent signaling on murine lymphocytes. Eur J Immunol 1998; 28: 2981–2990
   PubMed Web of Science ®Google Scholar
• Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol 2005; 17: 275–281
   PubMed Web of Science ®Google Scholar
• Jacquot S, Kobata T, Iwata S, Morimoto C, Schlossman SF. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: Enhancement of plasma cell differentiation by CD27 signaling. J Immunol 1997; 159: 2652–2657
   PubMed Web of Science ®Google Scholar
• Eris JM, Basten A, Brink R, Doherty K, Kehry MR, Hodgkin PD. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci USA 1994; 91: 4392–4396
   PubMedGoogle Scholar
• Barry F, Boynton R, Murphy M, Haynesworth S, Zaia J. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun 2001; 289: 519–524
   PubMed Web of Science ®Google Scholar
• Hathcock KS, Hirano H, Murakami S, Hodes RJ. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid. J Immunol 1993; 151: 6712–6722
   PubMed Web of Science ®Google Scholar
• Bohnhorst JO, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM. Bm1–Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome. J Immunol 2001; 167: 3610–3618
   PubMed Web of Science ®Google Scholar
• Li T, Zhong J, Chen Y, Qiu X, Zhang T, Ma D, Han W. Expression of chemokine-like factor 1 is upregulated during T lymphocyte activation. Life Sci 2006; 79: 519–524
   Google Scholar
• Peters T, Bloch W, Wickenhauser C, Tawadros S, Oreshkova T, Kess D, Krieg T, Muller W, Scharffetter-Kochanek K. Terminal B cell differentiation is skewed by deregulated interleukin-6 secretion in beta2 integrin-deficient mice. J Leukoc Biol 2006; 80: 599–607
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Kanneganti TD, Franchi L, Nunez G. Caspase-1 inflammasomes in infection and inflammation. J Leukoc Biol 2007; 82: 220–225
   PubMed Web of Science ®Google Scholar
• Husain Z, Holodick N, Day C, Szymanski I, Alper CA. Increased apoptosis of CD20+ IgA +B cells is the basis for IgA deficiency: The molecular mechanism for correction in vitro by IL-10 and CD40L. J Clin Immunol 2006; 26: 113–125
   PubMed Web of Science ®Google Scholar
• Stacey M, Bennett MS, Hulten M. FISH analysis on spontaneously arising micronuclei in the ICF syndrome. J Med Genet 1995; 32: 502–508
   PubMed Web of Science ®Google Scholar
• Pezzolo A, Prigione I, Facchetti P, Castellano E, Viale M, Gimelli G, Pistoia V. T-cell apoptosis in ICF syndrome. J Allergy Clin Immunol 2001; 108: 310–312
   Google Scholar
• Ke N, Godzik A, Reed JC. Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak. J Biol Chem 2001; 276: 12481–12484
   PubMed Web of Science ®Google Scholar
• Naumann U, Weit S, Wischhusen J, Weller M. Diva/Boo is a negative regulator of cell death in human glioma cells. FEBS Lett 2001; 505: 23–26
   PubMedGoogle Scholar
• Ivanov VN, Ronai Z, Hei TK. Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis. J Biol Chem 2006; 281: 1840–1852
   PubMed Web of Science ®Google Scholar
• Irie S, Hachiya T, Rabizadeh S, Maruyama W, Mukai J, Li Y, Reed JC, Bredesen DE, Sato TA. Functional interaction of Fas-associated phosphatase-1 (FAP-1) with p75(NTR) and their effect on NF-kappaB activation. FEBS Lett 1999; 460: 191–198
   PubMedGoogle Scholar
• Dromard M, Bompard G, Glondu-Lassis M, Puech C, Chalbos D, Freiss G. The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation. Cancer Res 2007; 67: 6806–6813
   Google Scholar
• Ehrlich M, Gama-Sosa M, Huang L-H, Midgett RM, Kuo KC, McCune RA, Gehrke C. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells. Nucleic Acids Res 1982; 10: 2709–2721
   PubMed Web of Science ®Google Scholar
• Saras J, Claesson-Welsh L, Heldin CH, Gonez LJ. Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-associated proteins. J Biol Chem 1994; 269: 24082–24089
   PubMed Web of Science ®Google Scholar
• Zhou YW, Komada Y, Inaba H, Azuma E, Sakurai M. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells. Cell Immunol 1998; 186: 103–110
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Kalai M, Saelens X, Declercq W, Vandenabeele P. Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity. J Biol Chem 2004; 279: 24785–24793
   PubMed Web of Science ®Google Scholar
• Nakai Y, Irie S, Sato TA. Identification of IkappaBalpha as a substrate of Fas-associated phosphatase-1. Eur J Biochem 2000; 267: 7170–7175
   Google Scholar
• Rawlings DJ, Sommer K, Moreno-Garcia ME. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nat Rev Immunol 2006; 6: 799–812
   PubMed Web of Science ®Google Scholar
• Lucas PC, McAllister-Lucas LM, Nunez G. NF-kappaB signaling in lymphocytes: A new cast of characters. J Cell Sci 2004; 117: 31–39
   PubMedGoogle Scholar
• Kim HP, Ryter SW, Choi AM. CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol 2006; 46: 411–449
   PubMed Web of Science ®Google Scholar
• Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, Soares MP. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem 2002; 277: 17950–17961
   PubMed Web of Science ®Google Scholar
• Soares MP, Usheva A, Brouard S, Berberat PO, Gunther L, Tobiasch E, Bach FH. Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide. Antioxid Redox Signal 2002; 4: 321–329
   PubMed Web of Science ®Google Scholar
• Uht RM, Amos S, Martin PM, Riggan AE, Hussaini IM. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway. Oncogene 2007; 26: 2885–2893
   Google Scholar
• Chen CC, Wang JK, Chen WC, Lin SB. Protein kinase C eta mediates lipopolysaccharide-induced nitric-oxide synthase expression in primary astrocytes. J Biol Chem 1998; 273: 19424–19430
   Google Scholar
• Pham TN, Brown BL, Dobson PR, Richardson VJ. Protein kinase C-eta (PKC-eta) is required for the development of inducible nitric oxide synthase (iNOS) positive phenotype in human monocytic cells. Nitric Oxide 2003; 9: 123–134
   PubMed Web of Science ®Google Scholar
• Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, Matsushita T, Yamazaki K, Ohnishi Y, Saito S, et al. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 2007; 39: 212–217
   PubMed Web of Science ®Google Scholar
• Quan T, Fisher GJ. Cloning and characterization of the human protein kinase C-eta promoter. J Biol Chem 1999; 274: 28566–28574
   PubMedGoogle Scholar
• Takata Y, Hamada D, Miyatake K, Nakano S, Shinomiya F, Scafe CR, Reeve VM, Osabe D, Moritani M, Kunika K, et al. Genetic association between the PRKCH gene encoding protein kinase Ceta isozyme and rheumatoid arthritis in the Japanese population. Arthritis Rheum 2007; 56: 30–42
   PubMed Web of Science ®Google Scholar
• Morrow TA, Muljo SA, Zhang J, Hardwick JM, Schlissel MS. Pro-B-cell-specific transcription and proapoptotic function of protein kinase Ceta. Mol Cell Biol 1999; 19: 5608–5618
   PubMedGoogle Scholar
• Niedbala W, Cai B, Liew FY. Role of nitric oxide in the regulation of T cell functions. Ann Rheum Dis 2006; 65(Suppl 3)iii37–iii40
   Google Scholar
• Zabel U, Weeger M, La M, Schmidt HH. Human soluble guanylate cyclase: Functional expression and revised isoenzyme family. Biochem J 1998; 335: 51–57
   PubMedGoogle Scholar
• Hartsfield CL. Cross talk between carbon monoxide and nitric oxide. Antioxid Redox Signal 2002; 4: 301–307
   PubMed Web of Science ®Google Scholar
• Montoliu C, Piedrafita B, Serra MA, Del Olmo JA, Ferrandez A, Rodrigo JM, Felipo V. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients. J Mol Med 2007; 85: 233–241
   Google Scholar
• Maekawa K, Imagawa N, Nagamatsu M, Harada S. Molecular cloning of a novel protein-tyrosine phosphatase containing a membrane-binding domain and GLGF repeats. FEBS Lett 1994; 337: 200–206
   PubMedGoogle Scholar
• Aoyama K, Suh SW, Hamby AM, Liu J, Chan WY, Chen Y, Swanson RA. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci 2006; 9: 119–126
   PubMed Web of Science ®Google Scholar
• Itoh T, Itoh A, Pleasure D. Bcl-2-related protein family gene expression during oligodendroglial differentiation. J Neurochem 2003; 85: 1500–1512
   PubMed Web of Science ®Google Scholar
• Burette A, Zabel U, Weinberg RJ, Schmidt HH, Valtschanoff JG. Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus. J Neurosci 2002; 22: 8961–8970
   PubMed Web of Science ®Google Scholar
• Gemma C, Bickford PC. Interleukin-1beta and caspase-1: Players in the regulation of age-related cognitive dysfunction. Rev Neurosci 2007; 18: 137–148
   PubMed Web of Science ®Google Scholar
• Masso-Welch PA, Winston JS, Edge S, Darcy KM, Asch H, Vaughan MM, Ip MM. Altered expression and localization of PKC eta in human breast tumors. Breast Cancer Res Treat 2001; 68: 211–223
   PubMedGoogle Scholar
• Lusser A, Kadonaga JT. Chromatin remodeling by ATP-dependent molecular machines. Bioessays 2003; 25: 1192–1200
   PubMed Web of Science ®Google Scholar
• Xiong Z, Laird PW. COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997; 25: 2532–2534
   PubMed Web of Science ®Google Scholar
• Ehrlich M. Expression of various genes is controlled by DNA methylation during mammalian development. J Cell Biochem 2003; 88: 899–910
   PubMed Web of Science ®Google Scholar
• Zhao Y, Srivastava D. A developmental view of microRNA function. Trends Biochem Sci 2007; 32: 189–197
   PubMed Web of Science ®Google Scholar
• Horn PJ, Peterson CL. Heterochromatin assembly: A new twist on an old model. Chromosome Res 2006; 14: 83–94
   PubMedGoogle Scholar
• Mathieu O, Bender J. RNA-directed DNA methylation. J Cell Sci 2004; 117: 4881–4888
   PubMed Web of Science ®Google Scholar
• Partridge JF, DeBeauchamp JL, Kosinski AM, Ulrich DL, Hadler MJ, Noffsinger VJ. Functional separation of the requirements for establishment and maintenance of centromeric heterochromatin. Mol Cell 2007; 26: 593–602
   PubMed Web of Science ®Google Scholar
• Alexiadis V, Ballestas ME, Sanchez C, Winokur S, Vedanarayanan V, Warren M, Ehrlich M. RNAPol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNA. Biochim Biophys Acta 2007; 1769: 29–40
   Google Scholar
• Jolly C, Metz A, Govin J, Vigneron M, Turner BM, Khochbin S, Vourc'h C. Stress-induced transcription of satellite III repeats. J Cell Biol 2004; 164: 25–33
   PubMed Web of Science ®Google Scholar
• Gasser SM. Positions of potential: Nuclear organization and gene expression. Cell 2001; 104: 639–642
   PubMed Web of Science ®Google Scholar
• Goldmit M, Ji Y, Skok J, Roldan E, Jung S, Cedar H, Bergman Y. Epigenetic ontogeny of the Igk locus during B cell development. Nat Immunol 2005; 6: 198–203
   PubMed Web of Science ®Google Scholar
• Alcobia I, Quina AS, Neves H, Clode N, Parreira L. The spatial organization of centromeric heterochromatin during normal human lymphopoiesis: Evidence for ontogenically determined spatial patterns. Exp Cell Res 2003; 290: 358–369
   Google Scholar
• Bartlett J, Blagojevic J, Carter D, Eskiw C, Fromaget M, Job C, Shamsher M, Trindade IF, Xu M, Cook PR. Specialized transcription factories. Biochem Soc Symp 2006; 67–75
   Google Scholar
• Shestakova EA, Mansuroglu Z, Mokrani H, Ghinea N, Bonnefoy E. Transcription factor YY1 associates with pericentromeric gamma-satellite DNA in cycling but not in quiescent (G0) cells. Nucleic Acids Res 2004; 32: 4390–4399
   PubMedGoogle Scholar
• Jolly C, Konecny L, Grady DL, Kutskova YA, Cotto JJ, Morimoto RI, Vourc'h C. In vivo binding of active heat shock transcription factor 1 to human chromosome 9 heterochromatin during stress. J Cell Biol 2002; 156: 775–781
   PubMedGoogle Scholar
• Day RN, Voss TC, Enwright JF, 3rd, Booker CF, Periasamy A, Schaufele F. Imaging the localized protein interactions between Pit-1 and the CCAAT/enhancer binding protein alpha in the living pituitary cell nucleus. Mol Endocrinol 2003; 17: 333–345
   PubMedGoogle Scholar
• Enwright JF, 3rd, Kawecki-Crook MA, Voss TC, Schaufele F, Day RN. A PIT-1 homeodomain mutant blocks the intranuclear recruitment of the CCAAT/enhancer binding protein alpha required for prolactin gene transcription. Mol Endocrinol 2003; 17: 209–222
   PubMedGoogle Scholar
• Piwien Pilipuk G, Galigniana MD, Schwartz J. Subnuclear localization of C/EBP beta is regulated by growth hormone and dependent on MAPK. J Biol Chem 2003; 278: 35668–35677
   PubMedGoogle Scholar
• Wen J, Huang S, Pack SD, Yu X, Brandt SJ, Noguchi CT. Tal1/SCL binding to pericentromeric DNA represses transcription. J Biol Chem 2005; 280: 12956–12966
   PubMedGoogle Scholar
• Yamashita K, Sato A, Asashima M, Wang PC, Nishinakamura R. Mouse homolog of SALL1, a causative gene for Townes–Brocks syndrome, binds to A/T-rich sequences in pericentric heterochromatin via its C-terminal zinc finger domains. Genes Cells 2007; 12: 171–182
   PubMed Web of Science ®Google Scholar
• Sabbattini P, Lundgren M, Georgiou A, Chow C, Warnes G, Dillon N. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J 2001; 20: 2812–2822
   PubMedGoogle Scholar
• Ugarkovic D. Functional elements residing within satellite DNAs. EMBO Rep 2005; 6: 1035–1039
   Google Scholar
• Netzer C, Rieger L, Brero A, Zhang CD, Hinzke M, Kohlhase J, Bohlander SK. SALL1, the gene mutated in Townes–Brocks syndrome, encodes a transcriptional repressor which interacts with TRF1/PIN2 and localizes to pericentromeric heterochromatin. Hum Mol Genet 2001; 10: 3017–3024
   PubMedGoogle Scholar
• Liu X, Wu B, Szary J, Kofoed EM, Schaufele F. Functional sequestration of transcription factor activity by repetitive DNA. J Biol Chem 2007; 282: 20868–20876
   PubMed Web of Science ®Google Scholar
• Ehrlich M, Ehrlich KC. Effect of DNA methylation on the binding of vertebrate and plant proteins to DNA. DNA methylation: Biological significance, JP Jost, HP Saluz. Birkhauser Verlag, Boston 1993; 145–168
   Google Scholar
• Nan X, Tate P, Li E, Bird A. DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol 1996; 16: 414–421
   PubMed Web of Science ®Google Scholar